NL-OMON43882已完成不适用
A Phase 1, Randomized, Double-blind, Placebo-Controlled, Single- and Multiple-Dose Escalation Study Evaluating Safety and Pharmacokinetics of VX-440 Alone and in Combination with VX-661/Ivacaftor, and Bioavailability and Food Effect of VX-440 in Healthy Adult Subjects - A Study to Evaluate Safety and PK of VX-440 in Healthy Adult Subjects
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •healthy male or female
- •18-55 y, incl.
- •BMI 18.0 - 31.0, and a total body weight >50 kg
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study
研究者
相似试验
招募中
1 期
A First-in-Human Study of SGB-9768 in Healthy VolunteersComplement-mediated DiseasesInflammatory and Immune System - Other inflammatory or immune system disordersACTRN12624000054516Sanegene Bio New Zealand Ltd36
尚未招募
1 期
A Study in Healthy Males and Females to Test How Different Doses of OPC-224333 are Tolerated (Arm 1)Neurological - EpilepsyEpilepsyACTRN12622000460707Otsuka Pharmaceutical Development & Commercialization, Inc72
尚未招募
不适用
A Phase 1 Study to Assess the Safety and Pharmacokinetics of GC1102 (Hepabig-Gene) in Healthy Male AdultsKCT0000473Green Cross33
已完成
1 期
A Phase 1, Single-Dose, Multiple-Dose, Food Effect and Drug-Drug Interaction Study of BPN14770Health ConditionJPRN-jRCT2031200182agata Tsutae112
招募中
不适用
A Phase 1, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Doses of PRAX-628 in Healthy Participants.Focal epilepsy10039911NL-OMON51482Praxis Precision Medicines112